This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Pharmachem Laboratories, Inc.
Drug Names(s): disodium ascorbyl phytostanol phosphates
Description: FM-VP4 represents a new class of cardiovascular pharmaceuticals known as cholesterol transport inhibitors. FM-VP4 is a water-soluble analogue of phytostanol, which has demonstrated significant lipid-lowering and anti-atherosclerotic properties in pre-clinical trials.
Deal Structure: FM-VP4 was originally developed by Forbes Medi-Tech.
In August 2010, Forbes Medi-Tech announced that the Company completed the previously announced sale of substantially all of its assets to Pharmachem Laboratories for cash consideration of US$4.0 million.
Pink Sheet Forbes Medi-Tech
Pink Sheet Chart: Weekly Trademark Review
Additional information available to subscribers only: